glp 1 patent expiration India's GLP-1 Moment Could Reshape Sugar Market Could GLP-1 Patent Expiration Impact

The GLP1 reset underscores how policy shifts can instantly redraw the value map across the healthcare ecosystem from pharma pricing to digital-first platforms built on subscription-based care

Massachusetts saw a 255 percent surge in obesity-related GLP-1 prescriptions in 2024 one of the highest increases in the country while Point32Health reported a $382 million loss last year and has begun layoffs amid mounting costs

This view suggests that semaglutide captures most of the available benefit from incretin-based therapy, and tirzepatides advantage comes from fine-tuning rather than fundamentally different mechanisms

Clinically used GLP-1 peptides (such as semaglutide) are chemically modified to resist enzymatic degradation and to achieve prolonged circulation time compared with native GLP-1